# SAM #FDA-CITELINE-1292051

HHS and FDA Sole Source Procurement for Citeline Trialtrove+ Subscription Services

**Buyer:** PSC Acquisition Management Services
**Posted:** September 23, 2026
**Respond By:** September 25, 2026
**Identifier:** FDA-CITELINE-1292051
**NAICS:** 513210, 511210

This opportunity is for the U.S. Department of Health and Human Services (HHS), including the Food and Drug Administration (FDA), to procure specialized subscription services for Citeline's Trialtrove+ clinical trial intelligence platform.
- Government Buyer:
  - U.S. Department of Health and Human Services (HHS)
    - Program Support Center Acquisition Management Service (ASA)
    - ASFR/OMAS office
    - U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER)
- OEMs and Vendors:
  - Citeline (OEM)
  - Caerus US 1 Inc. (reseller/contractor)
- Products/Services Requested:
  - Citeline Trialtrove+ subscription service
    - 30 Trialtrove+ licenses for FDA users
    - 2 one-hour training sessions (recordable by FDA)
    - 12 monthly FDA user metrics reports
- Unique/Notable Requirements:
  - Sole source procurement for Citeline Trialtrove+ data services
  - Subscription-based access to global clinical trial intelligence, supporting expedited IND Pilot Program
  - Training and user metrics reporting included
  - Requirement for comprehensive early-stage clinical trial data beyond ClinicalTrials.gov
  - Delivery and training timelines specified
- Estimated contract value: $87,000 for a one-year subscription
- Period of performance: One-year subscription, with option for renewal
- Citeline is the primary OEM, with Caerus US 1 Inc. as the designated reseller for this procurement.

### Description

<p>HHS requires access to Citeline data and related subscription services to support requirements in the Notice of Intent to Sole Soruce/Combined Synopsis-Solicitation and Attachment# 1 Statement of Work.</p>

[View original listing](https://sam.gov/opp/80d6e76b88e64014a574e3cceb22f11e/view)